Clinical Trial

Bladder Cancer Adjuvant Radiotherapy Trial

Study acronym: BART
Active, Not Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
Aim and objectives: This trial aims to evaluate the role of adjuvant radiotherapy following chemotherapy in patients with high-risk features on histo-pathology after radical surgery for transitional cell carcinoma of urinary bladder
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2016-10-28; most recent amendment 2025-02-11.
Status change: Recruiting → Active, Not Recruiting 2025-02-11
Trial Details
NCT Number NCT02951325
Lead Sponsor Tata Memorial Centre
Conditions Bladder Cancer, Urothelial Carcinoma Bladder
Enrollment 153 participants
Start Date 2016-06-02
Primary Completion 2024-05-08 (estimated)
Study Completion 2030-04-13 (estimated)
Updated on ClinicalTrials.gov 2025-02-13